| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Gault Cheryl serves as a Chief Operating Officer at RAPP. Across recent SEC filings that breaks down to 0 buys and 11 sells. Those positions are worth an estimated $4.7M at current prices.
The biggest single holding is RAPP (~$4.7M) as Chief Operating Officer. The recent filings there lean toward selling, a net 42,014 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | RAPP Rapport Therapeutics, Inc. | Chief Operating Officer | Sell | 10,000 | $33.19 | $331,856.34 | -6.7% | - | - | |
| Jun 30, 2026 | RAPP Rapport Therapeutics, Inc. | Chief Operating Officer | Sell | 10,000 | $41.58 | $415,797.77 | -6.3% | -19.8% | - | |
| Mar 30, 2026 | RAPP Rapport Therapeutics, Inc. | Chief Operating Officer | Sell | 10,000 | $28.19 | $281,857.12 | -5.9% | +45.9% | - | |
| Mar 5, 2026 | RAPP Rapport Therapeutics, Inc. | Chief Operating Officer | Sell | 2,014 | $28.93 | $58,265.02 | -1.2% | +24.5% | - | |
| Nov 26, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,000 | $30.10 | $150,486.50 | -2.8% | -1.5% | - | |
| Sep 8, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,000 | $38.33 | $191,650.00 | -2.8% | -4.2% | +46.5% |